Lithium Universe (ASX: LU7) chief executive officer Alex Hanly joins Small Caps to discuss the robust results obtained from the company's pre-feasibility study into its Bécancour refinery in Quebec, Canada.

The PFS confirmed the viability - even in a low pricing environment - of this key infrastructure element in Lithium Universe's critical metals development strategy.

The study further confirmed the value of Lithium Universe's counter-cyclical design where it will be able to develop projects at times of low prices that will be well placed when there is a recovery.

The company has also confirmed it is making good progress with offtake discussions with parties interested in its Lithium Conversion Gap strategy.

The company is now focussed on completing a full definitive feasibility study as it closes in on a Final Investment Decision for Bécancour.

Article:
https://smallcaps.com.au/lithium-universe-robust-becancour-refinery-pfs-results/

For more information on Lithium Universe:
https://smallcaps.com.au/stocks/asx-lu7/

Lithium Universe (ASX: LU7) chief executive officer Alex Hanly joins Small Caps to discuss the robust results obtained from the company's pre-feasibility study into its Bécancour refinery in Quebec, Canada.
The PFS confirmed the viability - even in a low pricing environment - of this key infrastructure element in Lithium Universe's critical metals development strategy.
The study further confirmed the value of Lithium Universe's counter-cyclical design where it will be able to develop projects at times of low prices that will be well placed when there is a recovery.
The company has also confirmed it is making good progress with offtake discussions with parties interested in its Lithium Conversion Gap strategy.
The company is now focussed on completing a full definitive feasibility study as it closes in on a Final Investment Decision for Bécancour.
Article: <a href="https://smallcaps.com.au/lithium-universe-robust-becancour-refinery-pfs-results/">https://smallcaps.com.au/lithium-universe-robust-becancour-refinery-pfs-results/</a>
For more information on Lithium Universe: <a href="https://smallcaps.com.au/stocks/asx-lu7/">https://smallcaps.com.au/stocks/asx-lu7/</a>

Small Caps is Australia's #1 site for investor news & information on ASX listed small cap companies. The podcast keeps investors informed by showcasing interviews with directors of ASX listed small cap companies and financial market analysts. For more information visit: https://smallcaps.com.au/.

Small Caps is Australia's #1 site for investor news &amp; information on ASX listed small cap companies. The podcast keeps investors informed by showcasing interviews with directors of ASX listed small cap companies and financial market analysts. For more information visit: https://smallcaps.com.au/.

The Small Caps podcast keeps stock market investors informed with the latest news by interviewing directors of ASX listed small cap companies and financial market analysts.

Small Caps

Small Caps is Australia's #1 site for investor news & information on ASX listed small cap companies.

The podcast keeps investors informed by showcasing interviews with directors of ASX listed small cap companies and financial market analysts.

For more information visit: https://smallcaps.com.au/

Lithium Universe (ASX: LU7) releases positive pre-feasibility study results for Bécancour refinery (w/ Alex Hanly)

Black Rock Mining (ASX: BKT) managing director and chief executive officer John de Vries joins Small Caps to discuss the company's recent signing of a major financing agreement to fund development of the Mahenge Graphite Project in Tanzania.

A consortium of African banks have come together to provide approximately $260 million in loan and bank guarantee facilities to fund Mahenge.

The financial institutions include The Development Bank of Southern Africa, The Industrial Development Corporation of South Africa and Tanzanian lender CRDB Bank.

The new facilities are in addition to around $73 million of previously agreed support from South Korean trading house POSCO, including a $58 million equity investment in Black Rock.

The funding support of the African banks is a major de-risking milestone for Black Rock towards funding the development of the Mahenge project.

Black Rock’s definitive feasibility study for the project has defined a four-stage construction schedule to deliver up to 340,000 tonnes per annum of 98.5% graphite concentrate for 26 years of 98.5% premium graphite flake concentrate with the ability to produce Ultra Purity flake of 99%.

Article:
https://smallcaps.com.au/black-rock-mining-mahenge-debt-financing-facility-african-banks/

For more information on Black Rock Mining:
https://smallcaps.com.au/stocks/asx-bkt/

Black Rock Mining (ASX: BKT) managing director and chief executive officer John de Vries joins Small Caps to discuss the company's recent signing of a major financing agreement to fund development of the Mahenge Graphite Project in Tanzania.
A consortium of African banks have come together to provide approximately $260 million in loan and bank guarantee facilities to fund Mahenge.
The financial institutions include The Development Bank of Southern Africa, The Industrial Development Corporation of South Africa and Tanzanian lender CRDB Bank.
The new facilities are in addition to around $73 million of previously agreed support from South Korean trading house POSCO, including a $58 million equity investment in Black Rock.
The funding support of the African banks is a major de-risking milestone for Black Rock towards funding the development of the Mahenge project.
Black Rock’s definitive feasibility study for the project has defined a four-stage construction schedule to deliver up to 340,000 tonnes per annum of 98.5% graphite concentrate for 26 years of 98.5% premium graphite flake concentrate with the ability to produce Ultra Purity flake of 99%.
Article: <a href="https://smallcaps.com.au/black-rock-mining-mahenge-debt-financing-facility-african-banks/">https://smallcaps.com.au/black-rock-mining-mahenge-debt-financing-facility-african-banks/</a>
For more information on Black Rock Mining: <a href="https://smallcaps.com.au/stocks/asx-bkt/">https://smallcaps.com.au/stocks/asx-bkt/</a>

Black Rock Mining (ASX: BKT) signs major Tanzanian project funding agreement (w/ John de Vries)

Tambourah Metals (ASX: TMB) chairperson Rita Brooks joins Small Caps to discuss the company's successful completion of its drilling at the Tambourah Gold project in Western Australia's far north.

The 11 hole RC and diamond drilling program targeted high-grade gold at the historic Tambourah King, Federal and Kushmattie prospects.

A Western Australian government co-funded diamond hole also tested gold mineralisation at the World’s Fair prospect.

The company is expecting assay results from the program to arrive early next month after noting promising geology during the drilling program.

At the same time Tambourah is progressing planning for an RC drill program at the Cheela Gold project and undertaking data analysis and drill targeting of the Bryah Copper-Gold project in WA’s Murchison region.

Article:
https://smallcaps.com.au/tambourah-metals-maiden-drilling-program-namesake-gold-project-wa/

For more information on Tambourah Metals:
https://smallcaps.com.au/stocks/asx-tmb/

Tambourah Metals (ASX: TMB) chairperson Rita Brooks joins Small Caps to discuss the company's successful completion of its drilling at the Tambourah Gold project in Western Australia's far north.
The 11 hole RC and diamond drilling program targeted high-grade gold at the historic Tambourah King, Federal and Kushmattie prospects.
A Western Australian government co-funded diamond hole also tested gold mineralisation at the World’s Fair prospect.
The company is expecting assay results from the program to arrive early next month after noting promising geology during the drilling program.
At the same time Tambourah is progressing planning for an RC drill program at the Cheela Gold project and undertaking data analysis and drill targeting of the Bryah Copper-Gold project in WA’s Murchison region.
Article: <a href="https://smallcaps.com.au/tambourah-metals-maiden-drilling-program-namesake-gold-project-wa/">https://smallcaps.com.au/tambourah-metals-maiden-drilling-program-namesake-gold-project-wa/</a>
For more information on Tambourah Metals: <a href="https://smallcaps.com.au/stocks/asx-tmb/">https://smallcaps.com.au/stocks/asx-tmb/</a>

Tambourah Metals (ASX: TMB) wraps up major gold drilling program (w/ Rita Brooks)

Anatara Lifesciences (ASX: ANR) executive chair Dr David Brookes joins Small Caps to discuss the company's progress with its Stage 2 pivotal GaRP irritable bowel syndrome trial.

The company has made good strides with recruitment for the trial, with over 30 participants enrolled and approximately 20 potential participants currently in the final screening to determine suitability for enrolment.

The company has added additional sites in Adelaide and the Sunshine Coast, while it is receiving sustained levels of interest at existing sites in Melbourne, Sydney, and Brisbane.

The Stage 2 trial is designed to confirm the highly encouraging and clinically meaningful interim results from Stage 1 of the GaRP-IBS clinical trial. 

GaRP is considered to have the potential to be a disease-modifying treatment that aims to positively impact a substantial proportion of the population suffering from the debilitating symptoms of digestive disorders, including irritable bowel syndrome.

Anatara recently received more than $626,000 from the Australian Taxation Office under the Federal Government’s Research and Development (R&D) tax incentive scheme for FY2024. 

Those funds will support Phase 2 of the clinical trial of GaRP.

Articles:
https://smallcaps.com.au/anatara-lifesciences-on-track-recruitment-stage-2-garp-ibs-trial/
https://smallcaps.com.au/anatara-lifesciences-stage-2-garp-trial-ibs-treatment-gains-momentum/

For more information on Anatara Lifesciences:
https://smallcaps.com.au/stocks/asx-anr/

Anatara Lifesciences (ASX: ANR) executive chair Dr David Brookes joins Small Caps to discuss the company's progress with its Stage 2 pivotal GaRP irritable bowel syndrome trial.
The company has made good strides with recruitment for the trial, with over 30 participants enrolled and approximately 20 potential participants currently in the final screening to determine suitability for enrolment.
The company has added additional sites in Adelaide and the Sunshine Coast, while it is receiving sustained levels of interest at existing sites in Melbourne, Sydney, and Brisbane.
The Stage 2 trial is designed to confirm the highly encouraging and clinically meaningful interim results from Stage 1 of the GaRP-IBS clinical trial. 
GaRP is considered to have the potential to be a disease-modifying treatment that aims to positively impact a substantial proportion of the population suffering from the debilitating symptoms of digestive disorders, including irritable bowel syndrome.
Anatara recently received more than $626,000 from the Australian Taxation Office under the Federal Government’s Research and Development (R&amp;D) tax incentive scheme for FY2024. 
Those funds will support Phase 2 of the clinical trial of GaRP.
Articles: <a href="https://smallcaps.com.au/anatara-lifesciences-on-track-recruitment-stage-2-garp-ibs-trial/">https://smallcaps.com.au/anatara-lifesciences-on-track-recruitment-stage-2-garp-ibs-trial/</a> <a href="https://smallcaps.com.au/anatara-lifesciences-stage-2-garp-trial-ibs-treatment-gains-momentum/">https://smallcaps.com.au/anatara-lifesciences-stage-2-garp-trial-ibs-treatment-gains-momentum/</a>
For more information on Anatara Lifesciences: <a href="https://smallcaps.com.au/stocks/asx-anr/">https://smallcaps.com.au/stocks/asx-anr/</a>

Lithium Universe (ASX: LU7) releases positive pre-feasibility study results for Bécancour refinery (w/ Alex Hanly)

In 1 playlist(s)

Small Caps

Social links

Follow podcast

Recent clips